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Director’s Report
2011 was a year of change and achievement  
for NACD.
In May 2011, following a change of Government, 
responsibility for the National Drugs Strategy 
was allocated to Róisín Shortall TD, Minister with 
Responsibility for Primary Care in the Department 
of Health, and consequently the office of the NACD 
transferred to Hawkins House.
In February, Director, Susan Scally left the NACD and 
was replaced by Eddie Arthurs, who left in March. 
Higher Executive Officer, Alan Gaffney, left the NACD 
in April. In December, Dr. Des Corrigan, Chair of NACD 
indicated that he would not seek re-appointment in 
2012.
In the midst of such flux the unstinting work of the 
NACD, its sub committees, research advisory groups  
and the Secretariat ensured that much was achieved.
The mandate of the NACD was renewed in 2009 up  
to the end of 2011 and a number of significant new 
work areas were agreed in a work plan for the period.
The details of the activities are detailed later in this 
report. Four projects were of particular significance  
and are highlighted here.
Firstly in September NACD published its Research and 
Data Management policy which outlines its policy 
on data management to ensure good governance 
and to comply with legal, ethical and professional 
responsibilities relating to data holding.
The second significant project was the publication 
of a literature review Parental Substance Misuse: 
Addressing its Impact on children. The report draws 
attention to gaps in our knowledge of the true extent 
and impact of parental substance misuse on children  
in Ireland.
The publication of new data from the third Drug Use 
in Ireland and Northern Ireland Drug Prevalence 
Survey 2010/11 provides an important measure of 
trends in drug use. Bulletin 1, First Results was published 
in November and revealed that recent and current 
levels of illegal drug use were mainly stable in Ireland 
between 2006/7 and 2010/11. The survey also captured 
new data on use of other opiates showing a higher 
prevalence amongst women, and new data on alcohol 
and cannabis dependency. Further detailed bulletins will 
be published in 2012.
Finally, in November the NACD published a paper, The 
Potency of THC in Cannabis products, prepared by the 
Forensic Science Laboratory analysing the potency of the 
main psychoactive component, tetrahydrocannabinol 
(THC), in herbal cannabis produced in Ireland. 
Internationally there is growing concern about the 
higher levels of THC and its effect on the brain. This 
is the first paper from a new series of NACD Research 
working papers published on our website. www.nacd.ie
It is appropriate that I acknowledge and thank the 
extensive commitment and expertise of the outgoing 
NACD and its Sub Committees and Research Advisory 
Groups whose term of office finished in December 
2011. They were most generous in their time and 
sharing of knowledge in implementing NACD’s work 
during the year.
I also wish to sincerely acknowledge and thank Minister 
Róisín Shortall TD, Dr. Des Corrigan, staff colleagues Dr. 
Justine Horgan and Mary Jane Trimble, colleagues in 
the Department of Health and in the various statutory, 
community and voluntary bodies working to reduce 
the impact of drugs on the lives of individuals, families 
and communities. Working towards this is an important 
shared responsibility and it was a privilege to contribute 
towards such a goal.
Joan O’Flynn 
Director
February 2012
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Chapter One
Background and Functions of the NACD
1.1 Origins
The NACD was established in July 2000 to advise 
the Government on problem drug use in Ireland in 
relation to consequences, prevalence, prevention, and 
treatment including rehabilitation, based on its analysis 
and interpretation of research findings and information 
available to it. It also provides ‘early warning’ advice to 
Government. The Committee comprises representation 
from government departments, academia, community, 
voluntary and statutory sectors.
Further to Government approval during 2009 of 
proposals for a new National Drugs Strategy (interim) 
2009-2016, the NACD mandate was extended until 
the end of 2011. NACD’s work programme is agreed 
annually with the Minister with responsibility for the 
National Drugs Strategy and the relevant drugs policy 
unit.
1.2 Functions
On its establishment in 2000, the functions of the 
NACD (the Committee) were agreed and remain as 
follows:
Based on the Committee’s analysis and interpretation 
of research findings and information available to it, 
to advise the Cabinet Committee on Social Inclusion 
and, through it, the Government, in relation to the 
prevalence, prevention, treatment and consequences  
of problem drug use in Ireland;
• to review current information sets and research 
capacity in relation to the prevalence, prevention, 
treatment and consequences of problem drug 
use in Ireland and to make recommendations, as 
appropriate, on how deficits should be addressed 
including how to maximise the use of information 
available from the community and voluntary sector,
• to oversee the delivery of a prioritised programme 
of research and evaluation as recommended by the 
Interim Advisory Committee to meet the gaps and 
priority needs identified by;
a) using the capacity of relevant agencies engaged 
in information gathering and research, both 
statutory and non-statutory, to deliver on 
elements of the programme,
b) liaising with these agencies with a view to 
maximising the resources allocated to delivering 
the programme and avoiding duplication;
c) coordinating and advising on research projects 
in the light of the prioritised programme,
d) commissioning research projects which cannot 
be met through existing capacity,
e) commissioning additional research at the 
request of the Government into drug issues  
of relevance to policy.
• to work with the Health Research Board on the 
establishment of a national information/research 
database (in relation to the prevalence, prevention, 
treatment and consequences of problem drug use) 
which is easily accessible, and
• to advise relevant agencies with a remit to promote 
greater public awareness of the issues arising in 
relation to problem drug use and to promote and 
encourage debate through the dissemination of its 
research findings.
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Chapter Two
Structures and Work Programme
2.1 Structures
2.1.1 The NACD
The NACD comprises 19 members who, with the 
exception of the Chairperson, participate on a voluntary 
basis. Since 2005, the Chairperson receives a small 
honorarium. Members serve at the invitation of the 
Minister and their participation requires them to sit 
on the NACD main committee and at least one sub-
committee. NACD meetings are generally scheduled  
to take place every six weeks excluding July and August. 
In 2011, seven meetings were held. Full membership  
is detailed in Appendix 1.
2.1.2 Sub-Committees
The NACD manages its work programme through five 
sub-committees that take responsibility for managing 
specific research projects related to their own area and 
reporting back to the NACD. The five sub committees 
are:
• Consequences,
• Early Warning Emerging Trends,
• Prevalence,
• Prevention,
• Treatment/Rehabilitation.
Each committee meets as required and according to 
the needs of the NACD work programme. In 2011, 
a total of 18 sub-committee meetings were held as 
follows: Consequences (1); Early Warning Emerging 
Trends (5); Prevalence (4); Prevention (4); and Treatment/
Rehabilitation (4).
2.1.3 Research Advisory Groups
All research has the support of a Research Advisory 
Group (RAG). The RAG comes together once the 
research question has been decided, usually by the 
relevant sub-committee. The RAG, which generally 
comprises relevant stakeholders or experts in the field, 
oversees the research process, coaching and mentoring 
the researchers, advising and guiding when appropriate 
and reviewing written output before finally signing off 
on a report for consideration by the sub-committee and 
finally the NACD.
2.1.4 Terms of Reference
The Terms of Reference for the NACD, its Sub-
committees and the RAGs have been noted in previous 
reports and are available on the website.
2.2 NACD Work Programme
The National Drugs Strategy (interim) 2009-2016 details 
the actions for which the NACD has lead responsibility. 
These actions are set out in Appendix 3 of this report.
2.2.1 Research Projects
Four research projects were advanced in 2011. In 
addition, a new Research Working Paper series, based 
on commissioned research was initiated. Progress on the 
research projects is reported first.
1. Drug Use in Ireland and Northern  
Ireland 2010/2011 Drug Prevalence Survey 
This is the third drug prevalence survey of households 
in Ireland and Northern Ireland conducted by the NACD 
and the Public Health Information and Research Branch 
within the Department of Health, Social Services and 
Public Safety in Northern Ireland. The fieldwork for the 
survey was carried out between October 2010 and May 
2011 with a final achieved sample of 7,669 respondents 
(5,134 in Ireland and 2,535 in Northern Ireland). The 
response rate was 60% in Ireland and 67% in Northern 
Ireland.
Respondents aged 15-64 were asked about their use of 
key illegal drugs, such as cannabis, ecstasy, cocaine and 
heroin on a lifetime (ever used), last year (recent use) 
and last month (current use) basis. They were also asked 
about the use of alcohol, tobacco and other drugs (e.g. 
sedatives and tranquillisers). The technical report is 
published on the NACD website.
First Results from the 2010/11 Drug Prevalence 
Survey (Bulletin 1) provides the key findings and 
statistically significant changes in prevalence rates 
between 2002/3, 2006/7 and 2010/11 which are 
presented in tabular format and discussed and 
compared in detail. Findings include;
• Recent and current levels of illegal drug use were 
mainly stable in Ireland between 2006/7 and 
2010/11,
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• cannabis remains the most commonly used illegal 
drug in Ireland, followed by new psychoactive 
substances and cocaine,
• men aged 15-24 were more than twice as likely as 
women to report recent use of cannabis and more 
than three times as likely to report use of new 
psychoactive substances and cocaine powder,
• there was greater usage of prescribed medicines 
and over the counter painkillers containing codeine 
amongst women,
• women and older adults reported higher levels of 
use of sedatives, tranquillisers and anti-depressants.
The remaining bulletins in the series will be published 
during 2012;
• Drug use by region,
• Alcohol consumption and harmful drinking,
• Cannabis, including other herbal ‘smokeable’ 
mixtures,
• Sedatives, tranquillisers and anti-depressants,
• Cocaine and other stimulants.
2. An Overview of New Psychoactive  
Substances and the Outlets Supplying Them 
Action 14 of the National Drugs Strategy (interim) 
2009-2016, provides for the monitoring of activities 
of ‘Head shops’ and all businesses involved in the sale 
of psychoactive substances to ensure no illegal activity, 
and to highlight gaps in our knowledge about these 
substances and their supply.
Following a competitive tendering process, Dublin 
Institute of Technology was commissioned in May 
2010 to review the psychoactive substances sold in 
‘Head shops’ and other outlets including internet sites. 
Since the study’s commencement in 2010 most of the 
substances which were openly sold in head shops have 
been made illegal (May 2010) and many head shops 
have closed.
The research found that illegal ‘head shop style’ 
products (new psychoactive substances) remain available 
online and some are being sold as food products. The 
report found that while online products may claim to be 
‘legal’, the products which were analysed all contained 
illegal substances.
Forty nine products sourced from Irish head shops and 
online outlets were analysed. Products were mostly in 
powder or tablet form. One was an herbal smoking 
product. Further research findings included;
• five products purchased online underwent analysis 
and all five contained illegal drug substances,
• all of the products purchased in head shops prior 
to the legislation on head shop products, contained 
substances that are now illegal,
• 79% of powder substances, 25% of tablet and 
33% of capsule products had no ingredients listed.
NACD policy recommendations suggested that 
efforts could be made to curtail such online trading, 
for example, through the co-operation between the 
Irish Medicines Board and the Customs authorities to 
monitor the sale of counterfeit medicines.
The NACD also recommended that the Department 
of Health monitor the emergence of new head shop 
products and move speedily to ban them.
A summary of key messages from the study was 
published in June 2011 and launched by Minister  
Róisín Shortall, TD. A full copy of the study is available 
on www.nacd.ie
3. The Prevalence of Drug Use, including 
Intravenous Drug Use, and Blood Borne  
Viruses among the Irish Prisoner Population 
A. Drummond, M. Codd, N. Donnelly, D McCausland,  
J. Mehegan, L. Daly and C. Kelleher
A study on the prevalence of drug use amongst the 
prison population in Ireland, which started in 2010, 
was completed in 2011. The purpose of the study was 
to determine the need for drug treatments and harm 
reduction (including needle exchange) services in Irish 
prisons. University College Dublin was commissioned to 
do this work and it was funded by NACD and the Irish 
Prison Service.
The study describes the nature, extent and pattern of 
consumption for different drugs, and the methods, 
including intravenous, of drug use among the prison 
population. The study estimates the prevalence of blood 
borne viruses, identifies associated risk behaviours 
among the prison population and measures the uptake 
of individual drug treatment and harm reduction 
interventions (including hep B vaccination) in prisons.
The findings of the study will be reported in 2012.
4. Drug Markets Study 
An independent editor was commissioned to finalise a 
study commissioned from the Health Research Board on 
illicit drug markets in Ireland. The study examines the 
factors which can influence the development of local 
drug markets, the nature, organisation and structure of 
Irish drug markets and the impact of drug dealing and 
drug markets on local communities.
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2.2.2 New Research Working Paper Series
The core task of the NACD is to advise Government 
about the of problem drug misuse in Ireland. In 
developing such advice the NACD reviews and evaluates 
published literature and data. In the course of these 
studies the NACD may obtain information and/or data 
which might not be included in the final report. This 
information could for example, explore methodological 
issues relating to a particular topic. It could also contain 
technical or scientific material which might not be of 
immediate interest to policy makers but which might be 
interesting to researchers or others working in similar or 
related fields. The NACD decided to make these papers 
available to a wider readership through a Working Paper 
Series to be published on the NACD website.
Three commissioned studies were finalised in 2011  
and published online on the NACD website as follows:
Research Working Paper No. I
The Potency of THC in Cannabis Product, by  
Colette Arnold, Forensic Science Laboratory
The research provides a baseline for measuring  
the potency of herbal cannabis produced in Ireland. 
Undertaken by the Forensic Science Laboratory (FSL), the 
research reported on the main psychoactive component 
of cannabis, Tetrahydrocannabinol (THC). The results 
presented in this report show that cannabis produced in 
Ireland has a higher potency than the imported variety.
The high quantity of THC in cannabis raises serious 
health concerns as recent UK studies have shown that 
there is a higher risk of psychosis in those who smoke 
high-potency cannabis products compared to those who 
smoke Hash which contains both THC & Cannabidiol 
CBD. While it is the high THC content and frequency 
of use of the former products that may cause psychotic 
episodes, it is also thought to be attributed to the 
amount or lack thereof of CBD, as CBD appears to 
decrease the effects of THC when ingested together.
The NACD hopes to update the data in this report on a 
regular basis given the increasing international concern 
about rising THC levels particularly in herbal cannabis 
of the “Skunk” variety. Allied to the increased levels of 
THC in these varieties is the absence of a second key 
chemical called CBD which seems to block some of the 
effects of THC on the brain. Accurate analysis of the 
levels of these natural chemicals in cannabis drugs is a 
time-consuming and technically complex process.
Research Working Paper No. 2
Methods and Data Sources for the Estimation  
of the Prevalence of Problematic Opiate and 
Cocaine Use in Ireland by Maria Gannon,  
Gordon Hay, Jennifer McKell
The University of Glasgow study identified statistical  
and practical adaptations to improve the reliability 
of the estimate generated by the capture/recapture 
method. The study identified data sources in Ireland that 
could be used to estimate the prevalence of problematic 
cocaine and opiate use applied a systematic approach  
to evaluating the usefulness of these methods.
Research Working Paper No. 3
Protocol for National Substance Misuse 
Rehabilitation Cohort Study Neil McKeganey,  
Gordon Hay
The University of Glasgow study provides information 
on the effectiveness of the different models to define, 
derive and measure a set of rehabilitation outcomes 
for problem drug and alcohol users in Ireland, and to 
provide an understanding of progression pathways to 
employment for recovering users.
2.2.3 NACD Internal Research
Parental Substance Misuse:  
Addressing its Impact on Children 
This report, by the NACD Senior Researcher Dr. Justine 
Horgan, reviewed all major international research on the 
impact of parental substance misuse on children and 
identified what steps can be taken in Ireland to reduce 
its impact.
The review looks, not only at the biological impact of 
drug use during pregnancy and breast feeding, but even 
more importantly highlights the psychosocial impact 
on children when their parents misuse drugs, including 
alcohol.
The review highlighted that children of substance 
misusers are more likely to experience problems with 
mental health, social skills, academic achievement 
and substance use. The recommendations from the 
review promote the need for more integrated working 
between addiction services, children’s services and 
medical professionals to help reduce the negative 
impact of parental drug and alcohol misuse on children 
and the wider family. They include:
• additional research and data collection to properly 
estimate the number of children whose parents 
have substance misuse problems,
• the Department of Children and Youth Affairs’ 
Children First guidelines to be used by all services 
and organisations working regularly with children 
who experience parental substance misuse and 
with their parents,
• assessing the extent to which adult alcohol and 
drug treatment services are supporting parenting 
and liaise with child support and other relevant 
services,
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• assessing the extent to which professional 
education and training in areas such as youth 
work, psychology, and addiction support, 
guidance, counselling and childcare can address 
children affected by parental substance misuse,
• education of women on the adverse effects of 
consuming alcohol and drugs during pregnancy 
and train medical professionals so that they can 
raise awareness among their patients of the risks  
of consuming these substances
• consideration of appropriate interventions and 
ways of working for primary health care staff who 
are involved in the early stages of children’s lives 
such as Public Health Nurses, GPs and community 
mothers.
A key messages document summarising the report was 
published and launched at a seminar in November (see 
report in chapter 3 of this annual report).
2.2.4 Collaboration
Collaborative working is a core principle of the NACD 
and every effort is made to involve stakeholders at 
various levels in relevant discussions, research projects 
and activities.
Over the last year the NACD has been very active in 
collaborating with colleagues in Northern Ireland on the 
third All Ireland Drug Prevalence Survey.
In addition, the NACD convened relevant stakeholders 
in the various RAGs to support other research projects, 
they included representatives from:
The Forensic Science Laboratory, Youthreach, State 
Laboratory, Beaumont Hospital, Drug Treatment Centre 
Board, Irish Medicines Board, Health Research Board, 
Barnardos, Food Safety Authority of Ireland, Citywide, 
Merchants Quay, Coolmine Therapeutic Community, 
Casadh, Dublin Aids Alliance, Ana Liffey Drug Project, 
Family Support Network, Health and Safety Authority, 
University College Dublin, Trinity College Dublin, 
University of Glasgow, Dublin Institute of Technology, 
National Youth Council of Ireland, Crosscare Drug and 
Alcohol Programme, Health Service Executive, Irish 
Prison Service, An Garda Síochána, Customs Drugs Law 
Enforcement Unit of The Revenue Commissioners and 
the Departments of Education and Skills, Justice and 
Equality and Health.
2.3 Performance Management
2.3.1 Staff
The NACD has four core posts, Director, Senior 
Researcher, Higher Executive Officer and Clerical Officer.
The HEO post became vacant in April. A business case 
was made to the Department of Health regarding the 
filling of the post. The vacancy continues.
2.3.2 Balanced Scorecard
In 2011 the NACD had an efficiency rate of 83%. 
This was comparable to the rate in 2010 and in the 
context of reduced staff levels is demonstrative of 
very high productivity and efficiencies. There were 25 
internal meetings some of which were team meetings 
held to manage the flow of work and to maintain the 
high levels of productivity from such a small team. 
The remaining meetings related to the work of sub-
committees, RAGs and visitors to the NACD.
Ministerial Briefings, advice to Government and 
information relating to Parliamentary Questions were 
provided on 12 occasions. There were 14 external 
meetings, relating to the provision of support to other 
agencies and to the research programme of the NACD. 
The NACD was also represented at meetings of the 
Oversight Forum on Drugs and other fora on five 
occasions.
In addition to commissioning and managing research, 
the work programme generates a range of other 
activities which adds another project management 
dimension to the operations of the NACD. Internal 
work includes providing secretariat support to the 
various committees, organising events, media relations 
and managing the publication process (which involves 
proofing, editing, checking in great detail all drafts 
going to and coming from the design house and 
co-ordinating the printing process). Each publication 
generates a series of activities related to planning 
and organising the dissemination of reports, to key 
stakeholders.
2.3.3 Freedom of Information (FOI)
A FoI reference book has been published on the website 
in accordance with the requirements of Sections 15 
and 16 of the FoI Acts. The purpose of this reference 
book is to facilitate access to official information held 
by the NACD, by outlining the structure, functions and 
details of the services provided by the NACD, how they 
may be availed of, information on the classes of records 
held, and information on how to make a request to the 
NACD under the Freedom of Information Acts, 1997 
and 2003. Section 16 of the FOI Act requires the NACD 
to publish a book containing the rules, procedures, 
practices, guidelines and interpretations used by the 
NACD.
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Chapter Three
Policy Advice and Public Communications
One of the core functions of the NACD is a commitment 
to communications in its broadest sense to promote 
and encourage debate and discussion of drug issues 
internally and externally amongst the wide range of 
stakeholders who interact with it.
The objectives of the communications strategy are:
• to provide timely advice to Government on key 
issues and emerging trends,
• to advise service providers and practitioners across 
sectors in relation to research findings that may 
inform current thinking and practice,
• to promote the research agenda amongst key 
influencers in those agencies and bodies that 
promote, commission, fund or undertake drug-
related research and/or have access to relevant data 
in this field,
• to represent the NACD and Ireland at international 
fora.
3.1 Advice to Government
The NACD provides ongoing advice to Government 
through its participation on the Oversight Forum on 
Drugs, in its briefings to the Minister and through 
recommendations made based on research or 
information it had considered. The NACD also provides 
advice and support to the Drugs Policy Unit, Department 
of Health in responding to parliamentary questions and 
general queries relating to its work.
National Drugs Strategy Structures Review
In response to a Ministerial consultation, a submission 
was made with policy recommendations relating to the 
Regional and Local Drugs Task Forces and the Oversight 
Forum on Drugs.
National Substance Misuse Strategy Group
Denis Bradley represented NACD on this Group.
National Action Plan on Social Inclusion
NACD advised on progress under actions attributed to 
it under the National Action Plan on Social Inclusion 
(NAPIncl). These referred to drug trends from the 2009 
Capture Recapture study and the 2006/7 National Drug 
Prevalence Survey and a note advising of the 2010/11 
National Drug Prevalence Survey.
Submission to the Department of 
Environment, Community and Local 
Government Statement of Strategy
In August the NACD made a submission to the 
Department of Environment, Community and Local 
Government Statement of Strategy. The submission re-
stated the recommendation on developing community 
indicators for problem drug use from the NACD study 
A Community Drugs Study, Developing Community 
Indicators for Problem Drug Use by Dr. Hilda Loughran 
and Dr. Mary Ellen McCann
Submission to Department of Children  
and Youth Affairs’ Statement of Strategy
The NACD made a short submission to the consultation 
on the development of the Department of Children and 
Youth Affairs’ Statement of Strategy.
Department of Health Consultation on 
re-scheduling of cannabis based medicinal 
products
Dr. Des Corrigan, Chair of NACD, participated in this 
consultation.
3.2 Policy Advice and Liaison
A range of policy advisory and policy liaison actions 
were undertaken with elected representatives and 
statutory bodies as follows:
Drugs Policy Unit in the Department  
of Health
Regular briefing meetings continued in 2011.
Joint Oireachtas Committee on Health  
and Children
In September the NACD appeared before the Joint 
Oireachtas Committee on Health and Children, to 
inform the Committee of its work and the NACD’s  
views on how to tackle the problem of drug misuse.
HSE National Addiction Advisory Governance 
Group (NAAGG)
In September, the Senior Researcher and Director briefed 
NAAGG on the key messages and recommendations 
from the literature review Parental Substance Misuse 
and its Impact on Children.
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HSE National Drug Rehabilitation 
Implementation Committee
Liam O’Brien NACD participated on this Committee.
HSE Overdose Prevention Strategy
Dr. Des Corrigan participated in the development of 
the Strategy, which proposes a role for the NACD in 
providing an objective review of supervised injecting 
facilities.
HSE Communications Protocol for Notification 
of Drug Use Emergencies
The Early Warning and Emerging Trends Sub Committee 
of the NACD developed an agreed framework to form 
the basis for an operational protocol to be developed by 
the HSE on clinical and public notification of drug use 
emergencies.
3.2.1 European Policy Advice
NACD members provided policy observations to the 
Department of Health on the European Commission 
‘Towards a Stronger European Response on Drugs’ 
and the Council of Europe Draft Conclusions on New 
Psychoactive Substances. It also contributed to the 
evaluation of the EU Drugs Strategy 2005-2012.
NACD, EU Drugs Strategy and the European 
Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA)
Under EMCDDA, Reitox is an EU wide information 
network on drugs and drug addiction. The Health 
Research Board is the Irish member or National Focal 
Point. The NACD collects national data required for two 
key indicators which are then reported on by the HRB 
to the EMCDDA. Under the new (2005-2012) EU Drugs 
Strategy, the data requirements for which the NACD is 
responsible relate to:
1. Drug use in the general population and specific 
populations
2. Numbers of problem drug users.
The three other key indicators which are harmonised  
at EU level are treatment demand; drug-related deaths 
and mortality and drug-related infectious disease.
Under the 1997 Joint Action Plan by the Council of the 
European Union concerning information exchange, risk 
assessment and control of new synthetic drugs, each 
member state had to set up a system of early warning 
on the emergence of this phenomenon. In 2001, that 
committee was placed on a formal basis within the 
NACD and its remit extended to include the monitoring 
of emerging trends.
Its work is now linked to work by the EMCDDA on early 
warning and emerging trends in drug use in the context 
of Council Decision 2005/387/JHA relating to New 
Psychoactive Substances.
3.3 Communications and Media
A total of 60 direct briefings/interviews were provided 
to the media in 2011. These were centred on promoting 
new research findings from NACD or responding to 
matters of public debate.
Four new reports/working papers were published and 
promoted in the media these related to new findings on 
drug prevalence in Ireland; new data on psychoactive 
substances; the impact of parental substance misuse 
on children and the potency of cannabis available 
in Ireland. These are detailed in Chapter 2 under 
Commissioned Research and Internal Research.
A seminar, co-hosted by NACD, HSE Social Inclusion and 
Alcohol Action Ireland was also promoted. See Section 
3.5 below for further details.
New information and data from NACD generated 
strong news coverage and public awareness particularly 
throughout the second half of the year.
3.4 NACD Website (www.nacd.ie)
The website contains all the necessary information 
about the NACD, including its vision, mission, values 
and functions, membership and sub-committee 
structure and the NACD’s programme of work. All 
NACD reports are published on the website and can be 
downloaded free of charge.
3.5 NACD Seminar
A Family Affair? Supporting children living  
with parental substance misuse.
In October the NACD together with HSE Social Inclusion 
and Alcohol Action Ireland co-hosted a Seminar in 
Croke Park to launch and discuss the findings from  
the literature review by Dr. Justine Horgan (NACD) 
Parental Substance Misuse: Addressing its  
Impact on Children – A Review of the Literature.
Over 100 people attended from a wide variety of 
statutory and voluntary organisations working in 
the area of substance misuse and rehabilitation, 
child protection welfare and support, community 
development, counselling services, probation service, 
family support services, doctors, social workers, 
psychologists and teachers.
N
A
C
D
 A
nnual Report 2011
9
The seminar provided the opportunity for discussion 
and debate between the services working with children, 
and those working with adults and enabled the sharing 
of observations and experiences and an exchange of 
views on the challenges involved in early intervention 
and interagency work in the context of diminishing 
resources.
The anticipated National Substance Misuse Strategy and 
the emerging Child and Family Agency were considered 
key policy initiatives that could incorporate a focus on 
children affected by parental substance misuse and that 
increase the emphasis on family support.
A full report on the seminar is available on the NACD 
website.
The event was addressed by Róisín Shortall TD, Minister 
with Responsibility for Primary Care and Frances 
Fitzgerald TD, Minister for Children and Youth Affairs.
3.6 NACD Publications – 2011
All NACD publications are available to download 
from www.nacd.ie/publications. 2011 publications, 
listed below were widely disseminated to statutory, 
community and voluntary bodies working on drugs-
related issues.
Annual Report
• NACD Annual Report 2010 published on the 
website only.
Early Warning and Emerging Drug Trends
New Psychoactive Substances
• An Executive Summary of an Overview of New 
Psychoactive Substances and the Outlets Supplying 
Them
• An Overview of New Psychoactive Substances  
and the Outlets Supplying Them
Cannabis Potency
• The Potency of THC in Cannabis Products
NACD Research Data Management Policy
• NACD corporate policy on data management  
and governance
Prevention of Drug Use
Parental Substance Misuse and its Impact on Children
• Parental Substance Misuse and Its Impact on 
Children: Key Messages and Recommendations 
from a Review of the Literature
• Parental Substance Misuse and Its Impact on 
Children: A Review of the Literature
• A Family Affair? Supporting Children Living with 
Parental Substance Misuse, Report of Seminar  
in October 2011
• Responding to challenges of substance use  
among young people, Report of a Seminar  
held in November 2010
Drug Prevalence
• Drug Use in Ireland and Northern Ireland: First 
Results from the 2010/11 Drug Prevalence Survey – 
Bulletin 1
• General Population Survey on Drug Prevalence 
2010/11 – Technical Report
• Research into Methods and Data Source for  
the Estimation of Prevalence and Problematic 
Opiate and Cocaine Use in Ireland
Treatment and Rehabilitation
• Protocol for National Substance Misuse 
Rehabilitation Cohort StudyN
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Chapter Four
Finance
4.1 Annual Budget
The annual budget for the NACD in 2011 was 
€700,000. Seventy per cent is allocated to research 
funding and the remaining thirty per cent to general 
administration.
The NACD budget is allocated through the Department 
of Health and can be examined by internal audit and 
the comptroller and auditor general.
Quarterly budget reports are made at the NACD 
meetings.
4.2 Expenditure in 2011
The summary of expenditure NACD’s allocation  
is detailed as follows:
 €
Salaries/honorarium 167,486
Administration 18,257
Research and PR 509,470
Total expenditure €695,213
N
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Appendix One
Membership of NACD Committee at 31st December 2011
Chairperson
Dr Des Corrigan, Visiting Academic
Vice-Chairperson
Dr Mary Ellen McCann, Academic Appointment
Members
Prof Joe Barry, Academic Appointment
Mr Denis Bradley, National Voluntary Drugs Sector
Mr Declan Byrne, Community Sector
Mr Michael Conroy, Dept of Health
Mr Joseph Doyle, Health Service Executive
Mr Tony Duffin, National Voluntary Drug Sector
Ms Deirdre Meenan, Dept of Justice & Equality
Dr Eamon Keenan, Consultant Psychiatrist, HSE
Dr Jean Long, Health Research Board
Ms Siobhan Kennan, Dept. of Health
Mr Charles R. Murphy, IAAAC
Mr Liam O’Brien, Community Sector
Dr Máirín O’Sullivan, Dept. of Education & Skills
Det Supt Michael D. O’Sullivan, An Garda Síochána
Ms Fiona Walsh, Health Service Executive
Retired NACD Members (2011)
Mr Tony Barden, Health Service Executive
Mr Bill Ebbitt Health Service Executive
Members of Sub-committees
(during 2011) (Not sitting on Main Committee)
Consequences
Dr Suzi Lyons, Health Research Board
Dr Cathal O’Sullivan, Health Service Executive
Ms Alison Reilly, Dept of Justice & Equality
Ms Anna Quigley, Dublin Aids Alliance
Mr Alan Kelly, Dept of Health
Early Warning/Emerging Trends
Ms Marita Kinsella, Dept. of Health
Dr Edel Duggan, Toxicology Department,  
Beaumont Hospital
Dr James Gray, Emergency Dept. AMNCH
Mr Gerry Hayes, Dept. of Justice & Equality
Ms Jelena Ivanovic, Crosscare Drug & Alcohol Programme
Dr Pierce Kavanagh, Trinity Centre for Health Sciences
Dr Richie Maguire, Medical Bureau of Road Safety
Ms Peggy McGlynn, Forensic Science Laboratory
Mr Chris Murphy, Crosscare Drug & Alcohol Programme
Ms Lorraine Nolan, Irish Medicines Board
Dr Dan O’ Driscoll, Forensic Science Laboratory
Ms Noreen Quinn, Dept. of Health
Mr Liam Regan, State Laboratory
Det Sergeant Brian Roberts, Garda National Drugs Unit
Ms Maria Ryan, Revenue Commissioners
Dr Bobby Smyth, Health Service Executive
Ms Siobhan Stokes, Drug Treatment Centre Board
Dr Joe Tracey, Toxicology Department, Beaumont Hospital
Prevalence
Mr Barry O’Donnell, Dept. of Justice & Equality
Dr Bobby Smyth, Health Service Executive
Dairearca Ní Néill, Dept of Health
Prevention
Mr Pat Hanna, RASP Community Addiction Rehab Centre
Ms Ger McHugh, National Youth Council of Ireland
Ms Dairearca Ní Néill, Drugs Policy Unit, Dept of Health
Ms Clare O’Reilly, Dept. of Health & Children
Ms Anna Quigley, Dublin Aids Alliance
Mr Conor Rowley, Dept of Children & Youth Affairs
Treatment/Rehabilitation
Mr Brendan Ryan, Dept of Health
Ms Elaine Butler, Homeless Agency
Mr Paul Conlon, Coolmine Therapeutic Community
Ms Miriam Conway, Dept of Social Protection
Mr Declan Byrne, Kilpatrick Coast Community Project
Ms Frances Nangle-Connor, Irish Prison Service
Mr Seamus Hempenstall, Dept. of Education & Skills
Dr Suzi Lyons, Health Research Board
Ms Siobhan Maher, Family Support Network
Mr Tim McCarthy, Dept. of Health
Dairearca Ní Néill, Dept of Health
Ms Elizabeth Toal, Homeless Agency
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Appendix Two
Actions Required of the NACD under the National Drugs 
Strategy (Interim) 2009-2016
49 Continue to implement and develop, 
as appropriate, the five key EMCDDA 
epidemiological indicators and the associated 
collection systems;
(i) Prevalence and patterns of drug use among 
the general population;
(ii) Prevalence and patterns of problem drug 
use.
54 Consider the further development of systems 
monitoring changing drugs trends in line with  
the EU Early Warning System
55 The Minister of State, the OMD and the NACD 
will develop and prioritise a research programme, 
revised on an annual basis. This would consider 
the following areas among others for possible 
research;
• Areas of research recommended in the 
report of the Working Group on Drugs 
Rehabilitation;
• Harm reduction approaches, based on 
an evidence-based approach covering 
developments internationally;
• Examining the evidence of the effectiveness 
of the progression of clients from substitute 
maintenance treatments to abstinence;
• Psychosocial adjustment, and quality of 
life, of patients on long-term methadone 
maintenance treatment;
• Examining the misuse and prolonged use  
of psychotropic drugs;
• Factors influencing deaths that are indirectly 
related to drugs;
• New developments in treatments for drugs;
• The impact of alcohol and drugs on the Irish 
health and justice systems;
• Further research on psychiatric co-morbidity 
among drug users;
• Prevalence patterns of problem substance use 
among prisoners and homeless people; and
• Examining the feasibility of developing an 
indicator to monitor changes in the prevalence 
of substance misuse among youth at risk
56 Develop a research management framework 
in regard to problem substance use in Ireland. 
Disseminate research findings and models of  
best practice.
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